Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing
Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention
Who this might be right for
COVID-19
R-Pharm 100